Dicens

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dicens

Quick Facts

Property Description
Active ingredient Diclofenac
Forms Tablets, Injections, Suppositories, Gels, Ophthalmic Solutions
Pharmacological class Non-steroidal anti-inflammatory drug (NSAID)
General purpose Symptomatic relief of pain, inflammation, and fever
Origin Synthetic compound (Phenylacetic acid derivative)

What Type of Medicine is Dicens (Diclofenac)?

Dicens is a medicine that contains the active ingredient Diclofenac, a substance recognized for its inclusion in essential medicine lists. The drug is classified as a Non-steroidal anti-inflammatory drug (NSAID), which indicates its primary role as an anti-inflammatory agent, an analgesic (pain reliever), and an antipyretic (fever reducer). The core action of this formulation is clinically recognized for its potent effect in mitigating the body's response to pain and swelling.

Composition and Available Forms of Dicens

Diclofenac is a synthetic compound derived from Phenylacetic acid, and Dicens is typically formulated as a single-ingredient product. The medicine is prepared in numerous dosage forms, including standard tablets, solutions for injection (for parenteral administration), suppositories, topical gels, and dedicated ophthalmic solutions. The existence of these forms is critical as they determine the route of administration and the scope of its action: oral and injectable forms achieve a systemic effect, while topical preparations are optimized for a concentrated local effect at the application site.

What is the General Purpose of Dicens?

The general purpose of Dicens is to provide direct symptomatic relief by modulating the body’s inflammatory responses. The fundamental mechanism involves the inhibition of prostaglandin synthesis, key chemical mediators that signal pain and promote swelling. The analgesic efficacy of Diclofenac is established for treating acute painful conditions through its consistent effectiveness. This targeted action is why the medicine effectively reduces swelling, lessens tenderness, and alleviates the general discomfort associated with inflammatory processes, such as acute soft tissue strain.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Dicens?

Possible Side Effects and Safety Information

Dicens, containing Diclofenac, is an NSAID whose safety profile is strictly defined by government regulatory documents. Adverse reactions are classified by frequency and the physiological system affected.


Serious Safety Constraints and Adverse Reactions

Regulatory warnings highlight the risk of Serious Cardiovascular Thrombotic Events, including myocardial infarction and stroke, which can be fatal. This risk may increase with the duration of use and may occur early in treatment. Similarly, the medicine is associated with a risk of Serious Gastrointestinal Adverse Events, such as bleeding, ulceration, and perforation of the stomach or intestines. Serious reactions also include Hepatotoxicity (liver injury) and severe Skin Reactions (Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis).


Common Adverse Reactions and Systemic Effects

The most common adverse reactions (ge 1%), as defined in official labeling, are frequently related to the Gastrointestinal System (e.g., nausea, dyspepsia, abdominal pain) and the Nervous System (e.g., headache, dizziness). Other documented effects are observed in the Renal and Urinary System (fluid retention) and Dermatological System (pruritus, rash).


Population-Specific Safety Notes

Safety is conditional on patient factors and pre-existing conditions. Older adults are at a greater risk for serious gastrointestinal adverse events and fatal outcomes. Dicens is contraindicated for treating peri-operative pain after Coronary Artery Bypass Graft (CABG) surgery and in patients with established severe Congestive Heart Failure or Ischaemic Heart Disease. Use is generally avoided after 30 weeks gestation due to fetal risk.

Overdose and Emergency Response

The regulatory profile for Dicens (Diclofenac) overdose indicates that while large ingestion may sometimes be asymptomatic, it carries the documented potential for severe, life-threatening outcomes. Officially reported manifestations may include common signs such as nausea, stomach pain, diarrhea, drowsiness, dizziness, and tinnitus.

Severe outcomes that are explicitly documented in regulatory materials include acute renal failure, internal gastrointestinal bleeding, seizures (convulsions), and coma. A large overdose is noted to be highly harmful to both children and adults, and greater risk is officially recognized for the elderly and those with existing renal or hepatic impairment.

Emergency Actions and Management

Official guidance requires individuals to seek medical help right away for suspected large ingestions. Emergency help must be sought immediately if a severe hypersensitivity reaction, such as anaphylaxis, occurs.

Treatment and Monitoring:

  • No specific antidote is known for Diclofenac overdose.
  • Management is defined as strictly symptomatic and supportive treatment.
  • Procedural steps may involve administering activated charcoal to limit absorption.
  • Hospital observation is required, potentially including ECG and blood and urine tests to assess organ function.

Therapeutic Uses of Dicens

What Dicens Treats: Main Uses and Benefits

Dicens (Diclofenac) is applied across domains where additional symptomatic support is needed in conditions involving inflammatory or irritative processes. It is relevant in contexts marked by increased discomfort or tension, and may assist with symptoms related to physical discomfort.

The medication is often used during phases when symptoms become more noticeable across conditions presenting with systemic or localized discomfort, such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is also relevant for easing acute or disruptive episodes like gout attacks or colic. Furthermore, it is applied in conditions associated with acute or episodic changes, such as the acute pain of primary dysmenorrhea, and discomfort linked to soft-tissue injuries or minor surgical procedures.

“The medication is commonly used to provide supportive relief when symptoms become more noticeable. It contributes to improved comfort during periods of heightened symptoms, which may assist with maintaining functional stability.”

It provides support that helps ease the overall symptom burden. This assists patients during episodes of heightened discomfort, which may support general well-being during symptomatic phases.

Quick Fact: Symptoms Relieved
Symptoms Relieved Joint pain, stiffness, swelling, tenderness, and fever accompanying acute inflammation.
Relevant Contexts Commonly used across conditions presenting with systemic or localized discomfort, or during acute episodes like colic.
Symptomatic Support Contributes to improved comfort and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Dicens (Diclofenac) — Official Regulatory Information


Eligibility Scope

Populations for whom use is allowed (as stated in label):

  • Adults (18 years and older).
  • Pediatric patients aged ge12 years for certain systemic forms where safety is established.

Populations for whom use is contraindicated:

  • Known hypersensitivity to Dicens or any NSAID (e.g., aspirin-sensitive asthma).
  • Treatment of perioperative pain in Coronary Artery Bypass Graft (CABG) surgery.
  • Active gastrointestinal ulceration, bleeding, or perforation.
  • Established congestive heart failure (NYHA Class II-IV) and ischaemic heart disease.

Age-related eligibility rules:

  • Minimum Age: Use is not established for most systemic forms in children younger than 12 years of age.

Condition-specific eligibility rules:

  • Renal/Hepatic Impairment: Use should be avoided in advanced renal disease or severe heart failure. Caution is required with hepatic impairment.

Pregnancy and lactation eligibility status (if explicitly documented):

  • Pregnancy (Third Trimester): Contraindicated (starting at 30 weeks gestation).
  • Lactation: Use with caution (excreted into human milk; requires benefit/risk assessment).

Eligibility Classifications (High-Level)

Eligibility severity classification (as defined in official documents):

  • Contraindicated (Absolute Non-Eligibility)
  • Avoid Use (Strong Restriction)
  • Not Established (Insufficient data)

Regulatory basis (EMA / FDA / etc.):

  • FDA / DailyMed Prescribing Information
  • EMA / SmPC (Summary of Product Characteristics)

Eligibility-context constraints (as defined in official documents):

  • Hypersensitivity Status
  • Perioperative Period (CABG)
  • Stage of Pregnancy

Resulting Eligibility Structure

Official regulatory documents establish absolute prohibitions based on hypersensitivity, active GI disease, and severe cardiovascular status. Use is further restricted by age, with most systemic forms not established for children under 12, and is strictly prohibited in the third trimester of pregnancy. Conditional use applies to patients with organ impairment and the elderly, requiring cautious management and monitoring.

What should I know about interactions with other medicines?

Dicens (Diclofenac) Interactions with other medicines and products are officially documented across several categories, primarily focusing on managing risk intensification and pharmacokinetic alteration. Co-administration is formally contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Furthermore, regulatory bodies generally recommend against combining Dicens with other systemic Non-steroidal Anti-inflammatory Drugs (NSAIDs) due to a lack of added benefit and a significantly increased risk of serious gastrointestinal adverse events.

The drug carries a documented risk of additive effects when combined with agents that affect bleeding. This includes Anticoagulants, Antiplatelet agents, Systemic Corticosteroids, and Selective Serotonin Reuptake Inhibitors (SSRIs), where the risk of hemorrhage is increased. Dicens may also diminish the efficacy of certain blood pressure medications, such as ACE Inhibitors and Diuretics, and can increase the risk of renal function deterioration when co-administered, especially in the elderly or those with volume depletion.

A separate class of interactions involves pharmacokinetic changes. Dicens exposure (Cmax and AUC) increases substantially when co-administered with strong CYP2C9 inhibitors (e.g., Voriconazole). Conversely, Dicens can cause an increase in the plasma concentrations of Lithium and Digoxin due to reduced renal clearance, necessitating close regulatory oversight. The risk of stomach bleeding is also increased when Dicens is combined with alcohol, and food consumption may delay the rate of absorption.

Mechanism of Action

How Dicens Works

Inhibition of the Cyclooxygenase-2 (COX-2) Enzyme

This core mechanism involves the drug acting as an inhibitor of the Cyclooxygenase-2 (COX-2) enzyme, which is responsible for synthesizing prostaglandin messengers at sites of tissue irritation. By blocking this conversion, Dicens suppresses the generation of key chemical mediators, which structurally reduces local vasodilation and plasma exudation.


Central and Peripheral Modulation of Nociceptive and Hypothalamic Pathways

Dicens employs a dual mechanistic approach, influencing pain signaling both peripherally and within the Central Nervous System (CNS). Beyond the primary enzyme inhibition, it modulates other non-prostaglandin pathways, such as Acid-Sensing Ion Channels (ASICs), to modulate the excitability of nociceptive neurons. Furthermore, by reducing prostaglandin signaling in the hypothalamus, the drug facilitates the adjustment of an elevated hypothalamic temperature set-point.


Consequences of Non-Selective Cyclooxygenase Inhibition

The drug's mechanism extends to inhibiting the constitutive Cyclooxygenase-1 (COX-1) isoform, which produces cytoprotective prostaglandins necessary for physiological homeostasis, such as maintaining the integrity of the stomach lining. This functional characteristic involves the molecular action affecting homeostatic pathways, resulting in a reduction in the synthesis of cytoprotective prostaglandins.

Dosage and Administration Information

How to Use Dicens

Dicens (Diclofenac) administration is defined by a set of official protocols that mandate the correct route, dosage limits, and timing, derived from authoritative regulatory documents. The medicine is prepared for both systemic use (via oral, rectal, and parenteral routes) and localized use (via topical and ophthalmic solutions), with the chosen form determining the site of action.

Official Dosing and Administration Patterns

Systemic dosing involves fixed daily ranges and schedules. For chronic conditions like osteoarthritis, the total daily dose generally falls between 100 mg and 150 mg, often administered in divided doses two or three times daily. The official maximum daily dose varies by formulation, but adherence to the lowest effective dose for the shortest duration is a central principle for all systemic use.

Classification Official Administration Guideline
Frequency Pattern Once daily (Extended-Release forms) or two to four times daily (Immediate/Delayed-Release forms).
Intake Condition While most oral forms may be taken independently of meals, specific formulations, such as the oral powder for solution, must be taken on an empty stomach and mixed with water only.
Form Integrity Modified-release forms (e.g., delayed-release tablets) must be swallowed whole and cannot be crushed, chewed, or split, as this alters the prescribed release characteristics.
Population Principle Dosing for older adults should adhere to the lowest dose for the shortest time. No adjustment is required for the unchanged drug in mild-to-moderate renal dysfunction.

The overall use protocol requires that the need for continued symptomatic therapy be periodically re-evaluated to align with the regulatory constraint of minimizing exposure.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dicens (Diclofenac)

This overview details the structure of the official research and the types of studies regulators rely on for Dicens (Diclofenac). It summarizes what has been observed in clinical trials and highlights areas where data remains limited or uncertain.


Evidence Exploring Dicens in Chronic Inflammatory Joint Conditions

The research base relied upon by regulators for Dicens in chronic conditions like osteoarthritis and rheumatoid arthritis is founded on controlled clinical trials and subsequent large-scale data reviews. These studies are used in research exploring how symptoms change over time and examining patient-reported experiences related to outcomes related to physical discomfort and daily functioning or activity level.

Research for Osteoarthritis and Functional Measures

Studies in osteoarthritis (OA) have focused on short-term Randomized Controlled Trials (RCTs). These studies typically involved adult populations with symptomatic OA in major joints. Research examined outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level. Findings describe patterns observed in the studies related to pain scale measurements and changes in physical function scores during the observed periods. However, the majority of this evidence is concentrated on short follow-up durations (often 12 weeks or less), meaning there is limited information for long-term outcomes regarding the sustained maintenance of functional improvements.

Research for Rheumatoid Arthritis and Inflammatory Markers

For rheumatoid arthritis (RA), studies focused on studies exploring patterns related to symptoms for conditions characterized by fluctuating or episodic manifestations. Research examined measurements of inflammation, such as the number of swollen and tender joints, and patient-reported outcomes describing perceived discomfort and morning stiffness. Findings indicate measured changes were observed in some studies during the study period. While research describes patterns related to its role in studies exploring patterns related to symptoms, limitations exist because research exploring its impact on structural damage or disease modification was not the primary focus of these symptomatic trials.


Evidence Exploring Dicens in Acute Pain Scenarios

Research exploring Dicens’s role in acute pain scenarios is supported by systematic reviews synthesizing numerous, highly controlled Acute Pain RCT Models. These research scenarios focused on episodes where symptoms become more noticeable, such as post-operative pain or acute strains. Studies monitored outcomes describing episodic or acute changes. Research highlighted changes measured during the study period, particularly regarding the rapidity of measured pain scale changes and the magnitude of measured pain intensity changes achieved shortly after administration. This evidence contributes to the broader evidence landscape for short-term changes, but research applies only to the populations studied and provides limited insight into chronic pain states.


Scientific Uncertainty and Areas Where Data Are Still Emerging

While substantial evidence exists from studies focused on outcomes related to physical discomfort and inflammatory states, several research limitations are noted in the scientific literature. Follow-up durations were limited in many pivotal trials for chronic conditions, leading to limited information for long-term outcomes beyond one year. For some conditions, such as ankylosing spondylitis, the comparative evidence is lacking regarding whether continuous versus on-demand dosing affects structural outcomes. Overall, research provides context but not individual predictions, and evidence quality varies across studies of the indications explored.

Frequently Asked Questions (FAQ)

Common questions about Dicens (FAQ)

Q: How long does it typically take to feel the effect of Dicens?

According to official product information, the initial effect of Dicens may be observed within one week for certain chronic conditions. However, in some studies, it is described that up to two weeks or longer may pass before improvement in symptoms is observed.

Q: Is it okay to take Dicens with simple pain relievers like ibuprofen?

Official regulatory guidance generally recommends against combining Dicens with other systemic Non-steroidal Anti-inflammatory Drugs (NSAIDs), which includes common pain relievers like ibuprofen. This is due to the potential for an increased risk of serious gastrointestinal adverse events, as additional benefit is not typically observed.

Q: Is Dicens known to interact with herbal supplements?

Regulatory documents do not specifically list interactions with most individual herbal supplements, but official guidance emphasizes that patients should inform their healthcare provider about all prescription medications, over-the-counter products, and herbal supplements being used. This practice is important because the potential for unknown interactions may exist.

Q: Is it normal to feel a change in appetite after starting Dicens?

Official adverse reaction reports show that a change in appetite, including loss of appetite, has been reported in post-marketing experience. It is noted that loss of appetite may also be a symptom of liver injury (hepatotoxicity); official guidance notes that this observation may warrant medical evaluation.

Q: Can Dicens affect sleep patterns or cause insomnia?

Yes, official documents indicate that Dicens can cause certain effects on the nervous system. Reported adverse reactions include difficulty sleeping (insomnia) as well as drowsiness.

Q: Can Dicens cause skin issues or rashes?

Dicens is associated with the risk of various skin reactions, including common rash and severe reactions. The official product information also includes photosensitivity (increased skin sensitivity to sunlight) among the side effects reported in post-marketing experience.

Q: Is Dicens available as a generic medicine?

The active ingredient in Dicens, diclofenac, is a well-established compound. It is available in various generic versions, as well as multiple brand-name products.

Q: Does taking Dicens require any specific lifestyle changes?

Official warnings note that the risk of gastrointestinal bleeding is increased when Dicens is combined with alcohol. Furthermore, risk factors such as smoking are documented to potentially increase the risk of serious adverse events associated with this medication.

Q: Can Dicens interact with over-the-counter cold and flu medications?

Many cold and flu medications may contain other systemic NSAIDs or similar pain-relieving components. Official guidance warns against combining Dicens with other NSAIDs due to the potential for an additive risk of serious gastrointestinal events.

Q: Is it true that Dicens can cause weight changes?

Unexplained or rapid weight gain may be a sign of fluid retention, which is a documented side effect associated with this class of medication. Official guidance states that unexpected weight gain warrants medical evaluation, as it can indicate a more serious cardiovascular or renal issue.

Q: Does Dicens stay in your system for a long time?

The official clinical pharmacology section describes how the drug is metabolized and eliminated. Following systemic administration, the drug's concentration in the blood decreases relatively quickly, with a terminal half-life in the plasma of approximately two hours.

Q: Does Dicens affect fertility or reproductive health?

Official documents advise that, for women who are trying to conceive or who are experiencing difficulty conceiving, healthcare providers should consider the withdrawal of Dicens. This is because anti-inflammatory medicines are documented to temporarily and reversibly affect ovulation.

Q: What is the maximum duration of time people typically use Dicens?

Dicens is generally not intended for indefinite long-term use. Official guidelines emphasize using the lowest effective dose for the shortest duration possible and emphasizes the need for periodic re-evaluation for continued therapy.

Q: Does the research evidence for Dicens include real-world patient data?

Yes, while foundational evidence relies on controlled clinical trials (RCTs), official research documentation has utilized real-world evidence (RWE). This real-world information is often incorporated to further assess long-term tolerability, particularly for topical formulations.

Q: Is Dicens habit-forming or does it cause dependency?

Dicens (diclofenac) is classified by regulatory authorities as not a controlled substance. This classification means the medication is not designated as having a risk for abuse, dependency, or habit formation.

Q: How soon after starting Dicens should I expect to see maximum results?

The maximum or full effect of Dicens, especially when used for chronic conditions, is not immediate. Official information suggests that it may take several weeks of consistent administration to achieve the medication's full therapeutic benefit.

Q: What happens if a pregnant person accidentally takes Dicens?

Official regulatory instructions state that if a patient becomes pregnant or suspects pregnancy while taking Dicens, they must stop the medication immediately. This situation warrants immediately contacting a healthcare provider for urgent medical evaluation, according to official guidance.

Q: Is it safe to drive or operate machinery after taking Dicens?

Official documents indicate that Dicens generally should not affect the ability to drive or use machines. However, if a patient experiences known side effects like dizziness or blurred vision, they should avoid these activities until those symptoms resolve.

Q: Are there any long-term effects of taking Dicens for many years?

Dicens is not intended for use over many years. Regulatory warnings note that the risks of serious adverse events, including cardiovascular thrombotic events (such as heart attack or stroke), may potentially increase with the duration of use.

Q: Is Dicens approved for use in children or teenagers?

Use is not established for most systemic forms in children under 12 years of age. However, for certain conditions like juvenile arthritis, official documentation states that some specific formulations (such as tablets or suppositories) may be used in pediatric patients, sometimes starting from 12 months of age.

How should Dicens be stored and disposed of?

How to Store and Dispose of Dicens

The storage and disposal of Dicens must strictly follow the conditions specified in official regulatory labeling to maintain product integrity and ensure safety.

Storage Requirements

Oral forms of Dicens must be stored at Controlled Room Temperature, generally defined as 20°C to 25°C (68°F to 77°F). The medication must be kept in its original, tightly closed container and protected from light, moisture, and excessive heat. Liquid formulations, such as injections and ophthalmic solutions, require mandatory protection from freezing. Dicens must always be stored out of the reach and sight of children.

Disposal Instructions

Unused or expired Dicens should be disposed of via an authorized drug take-back program or mail-back program. If these are unavailable, the medicine can be discarded in the household trash by mixing it with an unappealing substance, placing it in a sealed container, and securing the mixture. Regulatory guidelines prohibit flushing Dicens down a toilet or drain unless explicitly instructed to do so on the product label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dicens found in:

A-Z Index: